BioCryst (BCRX) Q1 2026 Earnings Transcript
Source: Motley Fool
2026-05-06 15:11:37 ET
Image source: The Motley Fool.
Wednesday, May 6, 2026 at 8:30 a.m. ET
Need a quote from a Motley Fool analyst? Email pr@fool.com
BioCryst Pharmaceuticals Inc.
NASDAQ: BCRX
BCRX Trading
0.12% G/L:
$8.495 Last:
820,015 Volume:
$8.50 Open:
BCRX Latest News
May 27, 2026 07:00:00 am
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
May 13, 2026 07:00:00 am
BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026
May 06, 2026 07:00:00 am
BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update
BCRX Stock Data
$1,391,931,498
199,991,369
0.01%
88
N/A
Biotechnology & Life Sciences
Healthcare
US
Durham
